
Slope of Hope Blog Posts
Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
Pre-Sentence Memorandum
Tomorrow, Friday, November 18th, 2022, is literally judgement day for Elizabeth Holmes, the world-famous founder of Theranos. Although her fall from grace took vastly longer than, let’s say, Samuel Bankman-Fried’s, it was sensational enough to warrant books and movies. I can’t imagine how nervous she must be at this very moment. She lives about ten miles from where I do.
I’ve taken a glance or two at the sentencing memorandum her lawyers submitted to the judge who will decide her sentence (if any), and I wanted to share some thoughts before tomorrow when the news comes out. I am not sure precisely what time of day the news hits, but it’ll be sometime during the court’s business hours here on the west coast.
(more…)Oh, Tyler…..
I know something about attitude. Lord knows I can employ some of it myself, especially when the market is going my way (something I haven’t felt for any length of time since pre-market October 13th). But I’ve got to say, there’s some serious “attitude” over at Zerohedge that doesn’t sit right with me.
I’ve written about ZH before, since it was my favorite site for so many years. As I’ve mentioned in the past, the cliché with ZH was that no bear market would take place as long as they existed. I think that old saw should be updated to declare that no bear market can take place as long as they are bearish. They were steadfastly on the bear side from 2009-2021 but, inexplicably, have becoming absolutely enthusiastic melt-up supporters in recent weeks.

Cover Curse Champs
Mouse Trap
Walt Disney used to be one of the greatest stocks in the world. In recent years, however, thanks to some really bone-headed thinking on the part of its leadership, the company has become a train wreck. It has lost about 43% of its value in just a year’s time, and keep in mind, this isn’t some biotech start. This is a member of the Dow 30, for God’s sake.


